---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-024012"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:46:35.855454+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "low"
source: SEC EDGAR
---

# Lipocine files updated corporate presentation; no material facts disclosed in filing

## Summary
- Company filed an updated investor presentation as Exhibit 99.1 to its November 18, 2025 8-K.
- No financial results, guidance, or specific operational metrics were described in the filing.
- The presentation is used in meetings with investors and analysts; no new events announced.
- Filing contains only procedural updates under Item 8.01; no material news identifiable.

## SEC filing metadata
- accession: 0001493152-25-024012
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315225024012/0001493152-25-024012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315225024012/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-024012
- JSON: https://secwatch.observer/filing/0001493152-25-024012.json
- Plain text: https://secwatch.observer/filing/0001493152-25-024012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.